Melasma, Vitiligo, Post Inflammatory hyperpigmentation, Lentigo are some of the common pigmentary disorders that has been of cosmetic concern to many. At CIDP, we propose various protocols to substantiate claims across these pathologies. Over the past 19 years, CIDP has conducted over 30 studies on melasma, a skin condition characterised by light to dark brown or brown-grey coloured patches with symmetrical distribution involving the central part of the face including forehead, cheeks, nose, and chin.
Studies involving the comparative efficacy of novel treatments (including hydroquinone) or therapies in improving skin pigmentation are conducted at CIDP under regulated norms.
Our highly trained dermatologists and experts can visually assess the intensity, size, and homogeneity of pigmentary areas through standardised scales (MASI, MSS, PAHPI, VAS). Furthermore, our recent investment, the new upgraded VISIA CR5 now allows for even better imaging to illustrative claims or for image analysis.
LIVE & HYBRID All you need to know about preclinical and clinical testing is at…
Abstract Background Oxidative stress is a significant factor in skin aging and pigmentation, which can be precipitated…
Remote prescribing of cosmetic injectables is set to be banned within weeks in a landmark…